Cargando…
Understanding the Role of Comparative Clinical Studies in the Development of Oncology Biosimilars
Biosimilars have the potential to broaden patient access to biologics and provide cost savings for health care systems. During the development of a biosimilar, data that directly compare the proposed biosimilar with the reference product are required. Such comparative data are generated in a stepwis...
Autores principales: | Stebbing, Justin, Mainwaring, Paul N., Curigliano, Giuseppe, Pegram, Mark, Latymer, Mark, Bair, Angel H., Rugo, Hope S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106981/ https://www.ncbi.nlm.nih.gov/pubmed/32058846 http://dx.doi.org/10.1200/JCO.19.02953 |
Ejemplares similares
-
Clinical considerations for the development of biosimilars in oncology
por: Socinski, Mark A, et al.
Publicado: (2015) -
Assessing Clinical Equivalence in Oncology Biosimilar Trials With Time-to-Event Outcomes
por: Uno, Hajime, et al.
Publicado: (2019) -
Biosimilars in oncology
por: Tabernero, Josep
Publicado: (2018) -
The role of biosimilars in value-based oncology care
por: Patel, Kashyap B, et al.
Publicado: (2018) -
Current and future roles of biosimilars in oncology practice
por: Konstantinidou, Sofia, et al.
Publicado: (2020)